Mickelson Announcement Prompts Expedited Filing of Psoriasis Research Plan with FDA by Energex Systems, Inc. | Business Wire
Links shared publicly online about this topic.
- 963total visits
Mickelson Announcement Prompts Expedited Filing of Psoriasis Research Plan with FDA by Energex Systems, Inc. | Business Wire
ALLENDALE, N.J.--(BUSINESS WIRE)--A research plan that is designed to determine the degree of effectiveness of an experimental non-drug therapy known as ImmunoModulation for the treatment of psoriasis as a primary indication and psoriatic arthritis as a secondary indication, will be filed with the Federal Food and Drug Administration in an expedited manner. In a letter that was delivered to the FDA today, medical technology developer Energex Systems, Inc. requested a Pre – Investigational
View full resource at businesswire.com
Most Recently Shared on August 17, 2010 at 10:56 pm By:
Mickelson Announcement Prompts Expedited Filing of Psoriasis Research Plan with FDA by Energex Systems, Inc.: ALLE... http://bit.ly/bo8sfi
Advertisement
